디지털 바이오마커 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 서비스별, 기술별, 컴포넌트별, 용도별, 디바이스별, 최종사용자별, 기능별, 솔루션별
Digital Biomarkers Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, End User, Functionality, Solutions
상품코드:1947927
리서치사:Global Insight Services
발행일:2026년 02월
페이지 정보:영문 302 Pages
라이선스 & 가격 (부가세 별도)
한글목차
디지털 바이오마커 시장은 2024년 54억 달러에서 2034년까지 358억 달러로 성장하고, CAGR 약 22%를 나타낼 것으로 예측되고 있습니다. 디지털 바이오마커 시장은 건강 관련 데이터를 수집하고 생물학적 과정과 치료 반응의 정량화 가능한 지표로 변환하는 디지털 도구의 개발 및 활용을 포함합니다. 이 시장은 웨어러블 기기, 모바일 헬스 용도, 센서를 활용하여 실시간 인사이트를 제공합니다. 만성질환의 급증과 개인 맞춤형 의료에 대한 수요가 시장 성장을 견인하는 한편, AI와 데이터 분석의 발전은 디지털 바이오마커의 정확성과 신뢰성을 높이고 있습니다.
디지털 바이오마커 시장은 웨어러블 기술과 개인 맞춤형 헬스케어 솔루션의 발전에 힘입어 견조한 성장세를 보이고 있습니다. 이 분야에서는 실시간 건강 추적을 위한 스마트 센서 통합으로 생리적 모니터링 분야가 특히 두드러진 성장세를 보이고 있습니다. 심박수 및 수면 패턴 모니터링이 주요 하위 부문으로 부상하고 있으며, 이는 소비자의 적극적인 건강관리에 대한 관심을 반영하고 있습니다. 신경학적 바이오마커 분야도 이에 이어 정신건강에 대한 인식이 높아지면서 인지기능 평가 도구가 주목받고 있습니다. 원격 모니터링과 데이터 분석을 가능하게 하는 디지털 플랫폼은 환자 참여도를 높이고 임상 결과를 개선할 수 있는 모멘텀이 되고 있습니다. 제약업계가 디지털 바이오마커를 의약품 개발 및 개인 맞춤형 의료에 도입하여 치료 전략의 혁신과 정밀성을 촉진하고 있다는 점은 주목할 만합니다. 기술 기업과 의료 서비스 제공업체 간의 협력은 매우 중요하며, 기술 발전을 촉진하고 시장 범위를 확대하는 데 큰 역할을 하고 있습니다. 데이터 보안과 프라이버시에 대한 강조는 여전히 중요하며, 소비자의 신뢰와 규제 프레임워크 준수를 보장합니다.
시장 세분화
유형
생리학적 바이오마커, 행동 바이오마커, 인지 바이오마커
제품
웨어러블 디바이스, 모바일 애플리케이션, 소프트웨어 플랫폼
서비스
데이터 수집 서비스, 데이터 분석 서비스, 컨설팅 서비스
기술
머신러닝, 인공지능, 빅데이터 분석, 클라우드 컴퓨팅, 사물인터넷(IoT), 블록체인
컴포넌트
센서, 프로세서, 접속 모듈
용도
질병 진단, 의약품 개발, 환자 모니터링, 임상시험, 건강 증진 및 예방
디바이스
스마트폰, 스마트 워치, 피트니스 트래커, 의료기기
최종사용자
의료 제공자, 제약회사, 연구기관, 보험 회사, 환자
기능
실시간 모니터링, 예측 분석, 자동 알림, 데이터 시각화
솔루션
엔드 투 엔드 솔루션, 포인트 솔루션, 통합 솔루션
디지털 바이오마커 시장은 혁신적인 가격 전략과 신제품 도입에 초점을 맞추고 시장 점유율이 역동적으로 분포하는 것이 특징입니다. 주요 업계 기업들은 첨단 디지털 바이오마커 솔루션을 적극적으로 개발하고 있으며, 이러한 솔루션은 전 세계 의료 시스템에 점점 더 많이 통합되고 있습니다. 이러한 추세는 개인 맞춤형 의료에 대한 수요 증가와 디지털 헬스 기술의 통합에 의해 촉진되고 있습니다. 시장 환경은 또한 전략적 제휴와 파트너십을 통해 형성되고 있으며, 최첨단 디지털 바이오마커 제품의 개발 및 배포를 촉진하고 있습니다. 디지털 바이오마커 시장의 경쟁이 치열해지면서 각 업체들은 기술 혁신과 전략적 제휴를 통해 차별화를 꾀하고 있습니다. 특히 북미와 유럽의 규제 프레임워크는 제품 개발 및 시장 진출 전략에 영향을 미치며 시장 역학에 매우 중요한 역할을 하고 있습니다. 이러한 규제는 데이터 보안과 유효성 확보를 목적으로 하고 있으며, 경쟁 환경에 영향을 미치고 있습니다. 디지털 바이오마커가 환자 치료와 임상시험을 혁신할 수 있다는 가능성에 힘입어 시장에서의 투자가 급증하고 있습니다. 이러한 성장은 디지털 바이오마커의 효과적인 활용에 필수적인 인공지능(AI)과 데이터 분석 기술의 발전이 뒷받침하고 있습니다.
주요 동향과 촉진요인:
디지털 바이오마커 시장은 기술 발전과 헬스케어 분야의 디지털화 진전에 힘입어 견조한 성장세를 보이고 있습니다. 주요 동향으로는 인공지능(AI)과 머신러닝의 통합이 진행되면서 디지털 바이오마커의 정확도와 예측 능력이 향상되고 있다는 점을 꼽을 수 있습니다. 웨어러블 기술도 보급되어 개인 맞춤형 의료에 필수적인 실시간 건강 모니터링과 데이터 수집을 실현하고 있습니다. 또한, 만성 질환 증가 추세는 조기 진단 및 지속적인 모니터링 솔루션에 대한 수요를 촉진하고 있습니다. 디지털 바이오마커는 비침습적이고 비용 효율적인 방법으로 질병의 진행을 추적할 수 있어 의료진과 환자 모두에게 매력적인 선택이 될 수 있습니다. 또한, 환자 중심의 치료와 예방의학에 대한 관심이 높아지면서 조기 개입을 가능하게 하는 디지털 바이오마커의 개발이 촉진되고 있습니다. 원격 의료 서비스 확대에는 많은 기회가 존재하며, 디지털 바이오마커는 원격 환자 모니터링에서 중요한 역할을 할 수 있습니다. 건강 데이터의 민감성을 고려할 때, 데이터 보안과 프라이버시 보호 분야에서 혁신하는 기업이 경쟁 우위를 점할 가능성이 높습니다. 전 세계 헬스케어 시스템이 환자 치료 결과와 업무 효율성 향상을 위해 디지털 혁신을 수용함에 따라 이 시장은 지속적으로 확대될 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 시장 하이라이트
제3장 시장 역학
제4장 부문 분석
제5장 지역별 분석
제6장 시장 전략
제7장 경쟁 정보
제8장 기업 개요
제9장 당사에 대해
LSH
영문 목차
영문목차
Digital Biomarkers Market is anticipated to expand from $5.4 billion in 2024 to $35.8 billion by 2034, growing at a CAGR of approximately 22%. The Digital Biomarkers Market encompasses the development and utilization of digital tools to collect health-related data, transforming it into quantifiable indicators of biological processes or therapeutic responses. This market leverages wearable devices, mobile health applications, and sensors to provide real-time insights. The surge in chronic diseases and the demand for personalized medicine propel market growth, while advancements in AI and data analytics enhance the precision and reliability of digital biomarkers.
The Digital Biomarkers Market is experiencing robust growth, propelled by advancements in wearable technology and personalized healthcare solutions. Within this domain, the physiological monitoring segment excels, driven by the integration of smart sensors for real-time health tracking. Heart rate and sleep pattern monitoring emerge as leading sub-segments, reflecting consumer interest in proactive health management. The neurological biomarkers segment follows closely, with cognitive assessment tools gaining prominence due to rising awareness of mental health. Digital platforms facilitating remote monitoring and data analytics are gaining momentum, offering enhanced patient engagement and improved clinical outcomes. The pharmaceutical industry's adoption of digital biomarkers for drug development and personalized medicine is notable, fostering innovation and precision in treatment strategies. Collaborations between tech companies and healthcare providers are pivotal, driving technological advancements and expanding the market's scope. The emphasis on data security and privacy remains critical, ensuring consumer trust and compliance with regulatory frameworks.
Wearable Devices, Mobile Applications, Software Platforms
Services
Data Collection Services, Data Analysis Services, Consulting Services
Technology
Machine Learning, Artificial Intelligence, Big Data Analytics, Cloud Computing, Internet of Things (IoT), Blockchain
Component
Sensors, Processors, Connectivity Modules
Application
Disease Diagnosis, Drug Development, Patient Monitoring, Clinical Trials, Wellness and Prevention
Device
Smartphones, Smartwatches, Fitness Trackers, Medical Devices
End User
Healthcare Providers, Pharmaceutical Companies, Research Organizations, Insurance Companies, Patients
Functionality
Real-time Monitoring, Predictive Analytics, Automated Alerts, Data Visualization
Solutions
End-to-End Solutions, Point Solutions, Integrated Solutions
The digital biomarkers market is characterized by a dynamic distribution of market share, with a focus on innovative pricing strategies and the introduction of new products. Key industry players are actively launching advanced digital biomarker solutions, which are increasingly being integrated into healthcare systems worldwide. This trend is propelled by the rising demand for personalized medicine and the integration of digital health technologies. The market landscape is further shaped by strategic collaborations and partnerships, enhancing the development and deployment of cutting-edge digital biomarker products. Competition in the digital biomarkers market is intensifying, with companies striving to differentiate through technological innovation and strategic alliances. Regulatory frameworks, particularly in North America and Europe, play a pivotal role in shaping market dynamics, influencing both product development and market entry strategies. These regulations aim to ensure data security and efficacy, thus impacting the competitive landscape. The market is witnessing a surge in investment, driven by the potential for digital biomarkers to transform patient care and clinical trials. This growth is supported by advancements in artificial intelligence and data analytics, which are crucial for the effective utilization of digital biomarkers.
Geographical Overview:
The digital biomarkers market is witnessing robust growth, with distinct regional dynamics shaping its trajectory. North America leads the charge, propelled by technological advancements in healthcare and a strong focus on personalized medicine. The region's sophisticated healthcare infrastructure and significant R&D investments are key growth drivers. Europe follows, driven by an aging population and increasing prevalence of chronic diseases. The region's regulatory frameworks and emphasis on healthcare innovation further bolster market growth. Asia Pacific is emerging as a lucrative market, with rapid technological adoption and expanding healthcare access. Countries like China and India are at the forefront, leveraging large patient pools and government initiatives to drive digital biomarker adoption. Latin America and the Middle East & Africa represent nascent growth pockets. In Latin America, improving healthcare infrastructure and rising digital health awareness are propelling market expansion. Meanwhile, the Middle East & Africa are recognizing the potential of digital biomarkers in enhancing healthcare outcomes and fostering innovation.
Global tariffs and geopolitical tensions are significantly influencing the Digital Biomarkers Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are enhancing their focus on domestic digital health technologies to mitigate tariff impacts and bolster self-reliance. China's strategic pivot towards indigenous digital health solutions is driven by export restrictions and a desire to dominate the health tech sector. Taiwan remains pivotal in semiconductor production for digital biomarker devices but faces geopolitical vulnerabilities. The global digital biomarkers market is experiencing robust growth, driven by increasing healthcare digitization and personalized medicine trends. By 2035, market expansion will rely on resilient supply chains and strategic partnerships. Middle East conflicts could disrupt global supply chains, influencing energy prices and operational costs in the digital health sector.
Key Trends and Drivers:
The digital biomarkers market is experiencing robust growth, driven by technological advancements and increasing healthcare digitalization. Key trends include the integration of artificial intelligence and machine learning, enhancing the accuracy and predictive capabilities of digital biomarkers. Wearable technology is also gaining traction, providing real-time health monitoring and data collection, which is vital for personalized medicine. Furthermore, the rising prevalence of chronic diseases is propelling demand for early diagnosis and continuous monitoring solutions. Digital biomarkers offer non-invasive, cost-effective means to track disease progression, making them attractive to both healthcare providers and patients. Additionally, the growing focus on patient-centered care and preventive healthcare is fostering the development of digital biomarkers that facilitate early intervention. Opportunities abound in expanding telehealth services, where digital biomarkers play a crucial role in remote patient monitoring. Companies that innovate in data security and privacy protection will likely gain competitive advantages, given the sensitive nature of health data. The market is poised for sustained expansion as healthcare systems worldwide embrace digital transformation to enhance patient outcomes and operational efficiency.
Research Scope:
Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.
TABLE OF CONTENTS
1 Executive Summary
1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes
2 Market Highlights
2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Services
2.4 Key Market Highlights by Technology
2.5 Key Market Highlights by Component
2.6 Key Market Highlights by Application
2.7 Key Market Highlights by Device
2.8 Key Market Highlights by End User
2.9 Key Market Highlights by Functionality
2.10 Key Market Highlights by Solutions
3 Market Dynamics
3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
3.10.1 PORTER's 5 Forces Model
3.10.2 ANSOFF Matrix
3.10.3 4P's Model
3.10.4 PESTEL Analysis
4 Segment Analysis
4.1 Market Size & Forecast by Type (2020-2035)
4.1.1 Physiological Biomarkers
4.1.2 Behavioral Biomarkers
4.1.3 Cognitive Biomarkers
4.2 Market Size & Forecast by Product (2020-2035)
4.2.1 Wearable Devices
4.2.2 Mobile Applications
4.2.3 Software Platforms
4.3 Market Size & Forecast by Services (2020-2035)
4.3.1 Data Collection Services
4.3.2 Data Analysis Services
4.3.3 Consulting Services
4.4 Market Size & Forecast by Technology (2020-2035)
4.4.1 Machine Learning
4.4.2 Artificial Intelligence
4.4.3 Big Data Analytics
4.4.4 Cloud Computing
4.4.5 Internet of Things (IoT)
4.4.6 Blockchain
4.5 Market Size & Forecast by Component (2020-2035)
4.5.1 Sensors
4.5.2 Processors
4.5.3 Connectivity Modules
4.6 Market Size & Forecast by Application (2020-2035)
4.6.1 Disease Diagnosis
4.6.2 Drug Development
4.6.3 Patient Monitoring
4.6.4 Clinical Trials
4.6.5 Wellness and Prevention
4.7 Market Size & Forecast by Device (2020-2035)
4.7.1 Smartphones
4.7.2 Smartwatches
4.7.3 Fitness Trackers
4.7.4 Medical Devices
4.8 Market Size & Forecast by End User (2020-2035)
4.8.1 Healthcare Providers
4.8.2 Pharmaceutical Companies
4.8.3 Research Organizations
4.8.4 Insurance Companies
4.8.5 Patients
4.9 Market Size & Forecast by Functionality (2020-2035)
4.9.1 Real-time Monitoring
4.9.2 Predictive Analytics
4.9.3 Automated Alerts
4.9.4 Data Visualization
4.10 Market Size & Forecast by Solutions (2020-2035)
